Browsing Tag
LCAT deficiency
1 post
ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program
ABIONYX Pharma triples CER-001 sphingomyelin yield with proprietary synthesis, advancing its sepsis programme. Read the full strategic analysis.